Jonathan Bloomberg
Child & Adolescent Psychiatry · Northbrook, ILNPI 1336322924
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,725 and has fallen 54.6% since, to $783 in 2025.
Across 288 payments — averaging $11.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$664
- Otsuka America Pharmaceutical, Inc.$312
- Lundbeck LLC$263
- Johnson & Johnson$223
- Neos Therapeutics, LP$216
- Takeda Pharmaceuticals U.S.A., Inc.$173
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,40199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,448 in reported general payments places this provider in the 85th percentile of 124 child & adolescent psychiatry providers in Illinois.
See all child & adolescent psychiatry providers in Illinois →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QelbreeViloxazine Hcl | 13 | $8,957 |
| Gabapentin | 31 | $344 |
| Duloxetine Hcl | 26 | $230 |
| Bupropion XlBupropion Hcl | 13 | $184 |
| Escitalopram Oxalate | 24 | $176 |
| Mirtazapine | 12 | $174 |
| Alprazolam | 17 | $131 |
| Fluoxetine Hcl | 19 | $119 |
| Sertraline Hcl | 11 | $22 |
| Trazodone Hcl | 14 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Supernus Pharmaceuticals, Inc.Qelbree | $44 | $8,95713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 124 child & adolescent psychiatry providers in Illinois.
Other child & adolescent psychiatry in Northbrook
- Catherine JaselskisNorthbrook$2K
- Claudia WelkeNorthbrook$802
- Lerwut WongsarnpigoonNorthbrook$192
- Fareha MalikElgin$57K
- Gregory TeasHoffman Estates$36K
- Martins AdeoyeOrland Park$10K
- Daniel MartinezLombard$8K
- Khalid ArshadKankakee$8K
- Talat GhausHinsdale$6K
- Walter PedemonteOak Park$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.